Company / Current Assets
RAPT Therapeutics, Inc. Current Assets History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$235.2M
FY2024
5-year range
$115.6M / $252.7M
FY2020-FY2024
Trend
+45.4%
vs FY2023
Sector context
#173 of 214
Health Care
What the data says
RAPT Therapeutics, Inc.'s current assets of $235M is lower than 81% of companies in the Health Care sector (FY2024). Declined from $253M to $235M over the past 2 years.
Based on SEC 10-K filings.
$235M in FY2024 with a 5-year CAGR of +23.9%.
Declined from $253M to $235M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +6.8%
- 5-Year CAGR
- +23.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 214This company $235.2M Sector average $2.5B
▼
-90.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.9%, indicating consistent growth.
- In FY2024, current assets increased 45.4% year-over-year.
- Ranks #173 out of 214 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $235.2M | +45.4% |
| FY2023 | $161.8M | -36.0% |
| FY2022 | $252.7M | +30.9% |
| FY2021 | $193.0M | +66.9% |
| FY2020 | $115.6M | +43.6% |
| FY2019 | $80.5M | +23.7% |
| FY2018 | $65.1M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026